ClinicalTrials.Veeva

Menu

Safety Demonstration of Microneedle Insertion

University of British Columbia logo

University of British Columbia

Status

Completed

Conditions

Allergic Reaction to Nickel

Treatments

Device: Gold- or silver-coated, or uncoated nickel microneedles

Study type

Observational

Funder types

Other

Identifiers

NCT02995057
H14-02324

Details and patient eligibility

About

Hypodermic needles are conventionally used to deliver drugs and vaccines into the muscle of humans and animals. Side effects of these needle injections are pain, bleeding, and anxiety in patients. An alternative drug and vaccine delivery method is the use of hollow microneedles, which are sub-millimeter needle-like structures. Microneedles are pain- and bleeding-free, as they do not reach the nerve-endings and blood capillaries in the skin. As a result, they are better received by patients and do not induce needle anxiety. As the investigators' microneedles are made of gold- or silver-coated, as well as uncoated nickel, the purpose of this study is to observe their biocompatibility and inertness.

Enrollment

15 patients

Sex

All

Ages

18 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Proven nickel allergy

Exclusion criteria

  • Pregnancy

Trial design

15 participants in 1 patient group

Nickel allergic
Description:
Participants have proven nickel allergy
Treatment:
Device: Gold- or silver-coated, or uncoated nickel microneedles

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems